140 related articles for article (PubMed ID: 1501079)
1. Triazolines. XXI: Preformulation degradation kinetics and chemical stability of a novel triazoline anticonvulsant.
Freeke Hamelijnck MA; Stevenson PJ; Kadaba PK; Damani LA
J Pharm Sci; 1992 Apr; 81(4):392-6. PubMed ID: 1501079
[TBL] [Abstract][Full Text] [Related]
2. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
Pramar Y; Gupta VD
J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
[TBL] [Abstract][Full Text] [Related]
3. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
Parasrampuria J; Gupta VD
J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
[TBL] [Abstract][Full Text] [Related]
4. Degradation kinetics of phentolamine hydrochloride in solution.
Wang DP; Tu YH; Allen LV
J Pharm Sci; 1988 Nov; 77(11):972-6. PubMed ID: 3225760
[TBL] [Abstract][Full Text] [Related]
5. Degradation kinetics of metronidazole in solution.
Wang DP; Yeh MK
J Pharm Sci; 1993 Jan; 82(1):95-8. PubMed ID: 8429500
[TBL] [Abstract][Full Text] [Related]
6. Triazolines. XXIII. High-performance liquid chromatographic assay in rat blood for a novel triazoline anticonvulsant (ADD17014).
Stevenson PJ; Hamelijnck MA; Kadaba PK; Damani LA
J Chromatogr; 1991 Feb; 563(2):419-26. PubMed ID: 2056006
[TBL] [Abstract][Full Text] [Related]
7. Rational drug design and the discovery of the delta2-1,2,3-triazolines, a unique class of anticonvulsant and antiischemic agents.
Kadaba PK
Curr Med Chem; 2003 Oct; 10(20):2081-108. PubMed ID: 12871087
[TBL] [Abstract][Full Text] [Related]
8. Preformulation study of methazolamide for topical ophthalmic delivery: physicochemical properties and degradation kinetics in aqueous solutions.
Jiang S; Wang F; Zhu S; Zhang X; Guo Z; Li R; Xu Q
Int J Pharm; 2013 May; 448(2):390-3. PubMed ID: 23541985
[TBL] [Abstract][Full Text] [Related]
9. Triazolines. 34. Structure and stability relationships of novel delta 2-1,2,3-triazoline anticonvulsants.
Chow AH; Chiu FC; Damani LA; Kadaba PK
Pharm Res; 1996 Jan; 13(1):179-82. PubMed ID: 8668671
[No Abstract] [Full Text] [Related]
10. Degradation kinetics of a new cephalosporin derivative in aqueous solution.
Rattie ES; Zimmerman JJ; Ravin LJ
J Pharm Sci; 1979 Nov; 68(11):1369-74. PubMed ID: 41933
[TBL] [Abstract][Full Text] [Related]
11. Study on degradation kinetics of 2-(2-hydroxypropanamido) benzoic acid in aqueous solutions and identification of its major degradation product by UHPLC/TOF-MS/MS.
Zhang Q; Guan J; Rong R; Zhao Y; Yu Z
J Pharm Biomed Anal; 2015 Aug; 112():1-7. PubMed ID: 25935790
[TBL] [Abstract][Full Text] [Related]
12. Preformulation studies on imexon.
Kuehl PJ; Hoye WL; Myrdal PB
Drug Dev Ind Pharm; 2006 Jul; 32(6):687-97. PubMed ID: 16885124
[TBL] [Abstract][Full Text] [Related]
13. Degradation study of the investigational anticancer drug clanfenur.
Sluiter C; Kettenes-van den Bosch JJ; Hop E; van der Houwen OA; Underberg WJ; Bult A
Int J Pharm; 1999 Aug; 185(2):227-35. PubMed ID: 10460918
[TBL] [Abstract][Full Text] [Related]
14. Stability studies of gabapentin in aqueous solutions.
Zour E; Lodhi SA; Nesbitt RU; Silbering SB; Chaturvedi PR
Pharm Res; 1992 May; 9(5):595-600. PubMed ID: 1608888
[TBL] [Abstract][Full Text] [Related]
15. Stability study of the anticonvulsant enaminone (E118) using HPLC and LC-MS.
Abdel-Hamid ME; Edafiogho IO; Hamza HM
J Pharm Biomed Anal; 2002 Jan; 27(1-2):225-34. PubMed ID: 11682230
[TBL] [Abstract][Full Text] [Related]
16. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
Denora N; Potts BC; Stella VJ
J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
[TBL] [Abstract][Full Text] [Related]
17. Stability of ricobendazole in aqueous solutions.
Wu Z; Tucker IG; Razzak M; Medlicott NJ
J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
[TBL] [Abstract][Full Text] [Related]
18. Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
Zhu H; Meserve K; Floyd A
Drug Dev Ind Pharm; 2002; 28(2):135-42. PubMed ID: 11926357
[TBL] [Abstract][Full Text] [Related]
19. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin.
Fabre H; Eddine NH; Berge G
J Pharm Sci; 1984 May; 73(5):611-8. PubMed ID: 6330342
[TBL] [Abstract][Full Text] [Related]
20. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
